Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Open research · Psilocybin & psilocin

Trial pipeline

Track psilocybin trial phases, recruitment, sponsors and registry completion dates with country filters, source links, comparison and free data exports.

Free access · No subscription for research tools or data exports

Filter the development pipeline

Reset

4 trials match this view; 5 reported facilities; 5 have usable coordinates. Latest indexed registry check Nov 19, 2026 02:23 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.

Enrollment sum: 85 across 4 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.

Recorded study-start years

20231
20241
20251
20261

Current indexed registry status

Recruiting1
Active, not recruiting1
Terminated1
Unknown status1

Reported research conditions

Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.

Milestones to investigate

The table is ordered by reported primary completion date. Check whether the registry calls enrollment estimated or actual, when the record was last updated, and whether results have been published. Completion dates are not readout dates; no model-generated success probabilities are assigned.

For late-stage studies, choose PHASE3 above. For studies still underway, choose an exact recruitment status. Use sponsor and country filters to inspect a programme, then save records to compare their designs.

Matching trial records

4 matching registry records. Dates are registry milestones, not promised results announcements.
TrialSponsor and phaseStatusEnrollmentStart / primary completion / completionResearch workflow
Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study

NCT04718792

Alcohol Use Disorder (AUD)
Anders Fink-Jensen, MD, DMSci

PHASE2

Unknown status

Registry updated 2024-07-12

10

ACTUAL

2023-02-09
2024-07-21
2024-07-21
Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic Effects

NCT06624137

OCD · Major Depressive Disorder (MDD) · Alcohol Use Disorder (AUD) · Healthy Volunteer · Migraine · PTSD · PTSD - Post Traumatic Stress Disorder · Addiction · Tobacco Use Disorder · Obsessive Compulsive Disorder (OCD) · Opioid Use Disorder
Yale University

Phase not reported

Terminated

Registry updated 2026-07-09

5

ACTUAL

2024-12-12
2026-06-14
2026-06-14
PsiloStudy: A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)

NCT06853912

Alcohol Use Disorder (AUD) · PTSD
Nathan Brashares Sackett

PHASE2

Active, not recruiting

Registry updated 2026-08-13

40

ESTIMATED

2025-06-01
2026-11-01
2027-06-01
Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial

NCT07405606

Major Depressive Disorder (MDD) · Alcohol Use Disorder (AUD)
Centre for Addiction and Mental Health

PHASE2

Recruiting

Registry updated 2026-10-26

30

ESTIMATED

2026-03-23
2028-03
2028-06

Reported research facilities

Centre for Addiction and Mental HealthToronto, Ontario, Canada · Coordinates available
Psychiatric Center CopenhagenCopenhagen, Frederiksberg, Denmark · Coordinates available
Connecticut Mental Health CenterHamden, Connecticut, United States · Coordinates available
University of Washington Center for Novel Therapeutics in Addiction PsychiatrySeattle, Washington, United States · Coordinates available
West Haven VA Medical CenterWest Haven, Connecticut, United States · Coordinates available

This directory includes reported facilities with and without coordinates. For a country-filtered view, locations are labeled as selected-country sites or international sites of matching trials. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.